Trinity Biotech PLC

191 articles about Trinity Biotech PLC

• Trinity Biotech plc to Announce First Quarter 2020 Financial ResultsConference Call Scheduled for May 27, 2020 at 11:00am EASTERN

  5/14/2020

  Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the first quarter 2020 on Wednesday, May 27, 2020. The Company has scheduled a conference call for that same day, Wednesday, May 27, 2020 at 11:00am ET (4:00pm BST) to discuss the results of the quarter.  Interested parties can access the call by dialing:  

• Trinity Biotech announces Quarter 4 and Fiscal Year 2019 Financial Results

  3/31/2020

  Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended December 31, 2019 and fiscal year 2019.

• Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year 2019 Financial ResultsConference Call Scheduled for March 31, 2020 at 11:00am EASTERN

  3/24/2020

  Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter and fiscal year 2019 on Tuesday, March 31, 2020.

• Trinity Biotech Announces Results for Q3, 2019

  10/16/2019

  Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended September 30, 2019.

• Trinity Biotech plc to Announce Third Quarter Fiscal Year 2019 Financial ResultsConference Call Scheduled for October 16, 2019 at 11:00 am EASTERN

  10/15/2019

  Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the third quarter fiscal year 2019 on Wednesday, October 16, 2019.

• Trinity Biotech Announces Results for Q3, 2017

  10/26/2017

  Total revenues for Q3, 2017 were $25.6 million.

• Trinity Biotech To Announce 2017 Third Quarter Financial Results

  10/13/2017

• Trinity Biotech Announces Results for Q2, 2017

  7/20/2017

• Trinity Biotech Announces Results For Q1, 2017

  4/27/2017

• Trinity Biotech To Announce First Quarter Fiscal Year 2017 Financial Results

  4/18/2017

• Trinity Biotech Cuts Jobs in Shutdown of Swedish Facility, Withdraws Device App With the FDA

  10/4/2016

• Trinity Biotech Announces Quarter 3 Financial Results

  10/22/2015

• Trinity Biotech Announces Quarter 2 Financial Results Enrolment For The Meritas Troponin ACS Study Now Completed

  7/28/2015

• Trinity Biotech Plc To Announce Second Quarter Fiscal Year 2015 Financial Results

  7/17/2015

• Trinity Biotech Announces Quarter 1 Results -- EPS 17.4 Cents Dividend Of 22 Cents

  4/30/2015

• Trinity Biotech To Announce First Quarter Fiscal Year 2015 Financial Results

  4/23/2015

• Trinity Biotech Closes Offering Of $115 Million Of 4.00% Exchangeable Senior Notes Due 2045, Including Exercise In Full Of Option To Purchase Additional Notes

  4/10/2015

• Trinity Biotech Announces Filing Of 2014 Annual Report

  3/25/2015

• Trinity Biotech Announces Results For Q4 And Fiscal Year 2014

  3/3/2015

• Trinity Biotech Announces Recommencement Of U.S. Clinical Trials On Its Point-Of-Care, High Sensitivity Troponin I Product

  2/24/2015